论文信息 - Analysis of BCR–ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype - 字舞流文

Analysis of BCR–ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype

M. Dyer | L. Foroni | G. Gerrard | J. Stebbing | R. Clark | M. Griffiths | J. Irving | L. Wang | C. Craddock | K. Page | M. Wang | C. Eaves | D. Forrest | J. Khorashad | S. O'brien | J. Khorashad | A. Woolfson | X. Jiang | L. Karran | H. Grant | Richard E. Clark | Charles Craddock | Lihui Wang | Martin J. S. Dyer | L. Foroni | Justin Stebbing | Connie J. Eaves | Karen M. Page | Donna L. Forrest | Xiaoyan Jiang | Mike Griffiths | Stephen J. O'Brien | Julie Irving

[1] M. Lieber,et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.

[2] E. Kulinskaya. On two-sided p-values for non-symmetric distributions , 2008, 0810.2124.

[3] J. Apperley. Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia. , 2007, The Lancet. Oncology.

[4] C. Eaves,et al. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells. , 2007, Journal of the National Cancer Institute.

[5] Nick Goldman,et al. Variation in evolutionary processes at different codon positions. , 2006, Molecular biology and evolution.

[6] Zhongming Zhao,et al. Mutational spectrum in the recent human genome inferred by single nucleotide polymorphisms. , 2006, Genomics.

[7] Ping Chen,et al. Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor , 2004, Science.

[8] J. Melo,et al. Chronic myeloid leukemia--advances in biology and new approaches to treatment. , 2003, The New England journal of medicine.

[9] Jürg Zimmermann,et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.